Hot Topics and Practical Considerations for Protecting Human Research Participants
For a printable PDF 2020 agenda, click here.
Day One - Thursday
8:00 - 8:15 Registration and Continental Breakfast
8:15 - 8:30 Welcome and Introduction
8:30 – 9:30 How to Satisfy 46.111 Criteria for Approval Including Protections for Vulnerable Populations
Michelle Brignac, CIP, CHRC, OHSP Manager-Clinical Research Operations - Hematology Department, Office of Human Subjects Protection,
St. Jude Children’s Research Hospital
Ms. Brignac will address various dilemmas in consenting vulnerable populations. The session will look at three case studies and identify tools that can help to ensure the rights and welfare of subjects are protected. As a result of the session, attendees will be able understand 45 CFR 46.111 and the challenges to consent vulnerable populations and identify tools to help the participant in the consent process.
9:30 - 10:30 A Changing IRB World
Brian Stage, CIP, Research Compliance Consultant for Regulatory Affairs, Reliance, and Outreach, Indiana University Human Subjects Office
The Revised Common Rule has been in effect for a little over a year now. Researchers have probably noticed changes to the way they are interacting with their IRBs. Mr. Stage will discuss the changes that have had the biggest impact on researchers, why their IRBs made those changes, and what other changes they should look out for in the future.
10:30 – 10:45 Break
10:45 - 11:45 An overview of the Law and its Impact on Clinical Research
Sheila Sokolowski, JD, Associate Attorney, Partner, Hogan Marren Babbo & Rose, Ltd
This presentation will provide an overview of the law and the American legal system. It will include history and evolution and the interplay between law and research.
11:45 - 12:45 Lunch provided
12:45 – 1:45 REDCap Versatility of use: Unique solutions for commonplace problems
Dirk Orozco, BS, Associate Application Specialist, Vanderbilt University Medical Center
Storage and maintenance of study related documents is paramount especially when managing multiple studies. Mr. Orozco will discuss best pratices and how the Vanderbilt Coordinating Center utilizes REDCap to address study related challenges. Focusing on operational and personnel management utilizing REDCap databases in a format easily reviewed by monitors for compliance study compliance.
1:45 - 2:45 EConsent: Moving Towards Personalized Informed Consent
Leah Dunkel, MPH, Research Services Consultant, Vanderbilt University Medical Center
In an effort to address issues of transparency, appropriate patient understanding/research literacy, clinical trial efficiency, and regulatory compliance around informed consent, we have created a suite of tools within the REDCap software platform centered around meaningful collection and storage of electronic consent (eConsent). This eConsent framework seeks to provide a more personalized consent experience whereby users may be guided though a web-based consent document that utilizes avatars, contextual glossary information supplements, videos, images, text reader functions, branching questions for comprehension, and other features that can facilitate communication of information to patients in a culturally relevant manner respective of health literacy level. Ms. Dunkel will focus on describing the features of the eConsent platform, how to specifically build an eConsent, and how eConsent features can be used to support customization for the benefit of prospective participants.
2:45 - 3:00 Break
3:00 – 4:30 Challenges in the Conduct of Clinical Research
Elizabeth L Guy, BSN, CCRP, Clinical Research Supervisor, Office of Clinical Research- UC Davis Comprehensive Cancer Center
Conducting clinical research present numerous challenges. In this interactive session attendees will discuss and identify challenges in the conduct of clinical research in different scenarios and settings/organizations. Learners will analytically discuss solutions or resolutions to the identified challenges.
Day Two Friday, May 1, 2020
8:00 - 8:15 Continental Breakfast
8:15 – 9:15 The Informed Consent Process and the Role of the Research Participant Advocate
Wendy Hayes, MSN, RN, CPHON, Research Participant Advocate, Office of Human Subjects Protection, St. Jude Children’s Research Hospital
It is not good enough that we just inform possible participants of the required information about research studies. We must also ensure understanding. Ms. Hayes will detail the informed consent process and describe the role and responsibilities of the Research Participant Advocate during this discussion. As a result of attending this session, attendees will understand the required elements of an informed consent discussion and be able to describe the role and responsibilities of the Research Participant Advocate.
9:15 - 10:15 An Introduction to Gene Therapy Research and the Evolving Regulatory Requirements in The U.S.
Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, Director of BioSafety Services, Advarra
Gene therapy is a quickly growing area of research as the U.S. and other countries have begun issuing approvals. Recent regulatory changes, scientific advances and demographics have combined to create ideal conditions for a boom in gene therapy research, particularly in oncology. Mr. Eisenman will provide an introduction to the field of gene therapy research and discuss the evolving regulatory environment as well as strategies for institutions interested in conducting gene therapy research, including considerations for IRB and IBC review.
10:15 - 10:30 Break
10:30 – 11:30 Health Disparities in the United States and Implications for Clinical Trials Research
Cynthia R. Davis Ph.D., Associate Center Director, Clinical Trials Operations Cooperative Studies Program, Department of Veterans Affairs, Boston VA Healthcare System
Dr. Davis will begin with a brief overview of health disparities in the United States and a presentation of cultural components of health, including physician approaches to medical decisions, patients, and potential participants based on racial, ethnic, and social factors. The presentation will highlight the problem of under-representation of racial and ethnic minorities in clinical trials research and include a discussion on how we can improve the status of racial and ethnic minority health and representation. Addressing unconscious biases, engaging with cultural communities, recruitment and enrollments strategies, and promoting diversity among health care and clinical trials research professionals will be considered.
11:30 - 12:30 Lunch Provided
12:30 - 1:30 Ensuring Patient Safety Through Risk Based Monitoring
Jamie Harper, MHA, CCRP, Director of Clinical Research, Illinois CancerCare, P.C., Peoria, IL
In the changing environment of clinical research, there are areas in every research program where patient safety is at a higher risk. Ms. Harper will discuss these areas and provide tips on how to mitigate the risk through auditing techniques. This discussion will also review some process improvement tools that can be used in conjunction with risk based auditing.
1:30 – 2:30 Training as Part of Compliance
Gail Mayo, RN, CCRP, Research Nurse Specialist, Vanderbilt University Medical Center
Ms. Mayo will discuss the merging of why, who, what, where, when and how of protection of human research participants, compliance and training. Attendees will discuss practical approaches to training in the realm of research practice.
2:30 – 2:45 Break
2:45 – 3:30 Case Study: Research Fraud: Does the Punishment Fit the Crime?
Wendy Lloyd, BA, LPN, CCRP, Senior Clinical Quality Research Analyst, Vanderbilt Institute for Clinical and Translational Research
What if we change this one finding? What if we enroll a subject who barely misses the applicable inclusion criteria? Who will ever know? Ms. Lloyd will present research Fraud case studies to promote discussion surrounding consequences for the researcher, the research community and research subjects.